Anika Therapeutics, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
Anika Therapeutics, Inc. (ANIK) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $421.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-07-29
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $3.00K.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was -$2.00K, a 300.00% decline year-over-year.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-06-30 was $138.00K, a 13700.00% increase year-over-year.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $139.00K, a 286.11% increase from fiscal 2024.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $36.00K, a 71.20% decline from fiscal 2023.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $125.00K, a 380.77% increase from fiscal 2022.
- Anika Therapeutics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $26.00K, a 64.38% decline from fiscal 2021.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month as first filed | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month as first filed | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month as first filed | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $421.00K 10-Q · filed 2026-07-29 | |||||||
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.00K derived: sum of 2 quarters · filed 2026-03-03 | $139.00K derived: sum of 3 quarters · filed 2026-07-29 | $139.00K 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $136.00K derived: sum of 2 quarters · filed 2026-07-29 | $136.00K 10-Q · filed 2025-11-05 | $135.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $138.00K 10-Q · filed 2026-07-29 | $137.00K derived: sum of 3 quarters · filed 2026-07-29 | $138.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | -$1.00K derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-03-03 | $1.00K derived: sum of 4 quarters · filed 2026-03-03 | ||||
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $1.00K derived: sum of 3 quarters · filed 2026-03-03 | $36.00K 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.00K derived: sum of 2 quarters · filed 2025-11-05 | $37.00K 10-Q · filed 2025-11-05 | $78.00K 10-Q · filed 2024-11-04 | $61.00K derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $36.00K 10-Q · filed 2025-07-30 | $77.00K 10-Q · filed 2024-08-08 | $60.00K derived: sum of 3 quarters · filed 2026-03-03 | $58.00K derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2024-03-31 | $35.00K 10-Q · filed 2025-05-09 | $45.00K 10-Q · filed 2024-05-08 | $59.00K derived: sum of 2 quarters · filed 2026-03-03 | $57.00K derived: sum of 3 quarters · filed 2026-03-03 | $54.00K derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $22.00K derived: sum of 2 quarters · filed 2026-03-03 | $19.00K derived: sum of 3 quarters · filed 2026-03-03 | $125.00K 10-K · filed 2026-03-03 | $153.00K 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$5.00K derived: sum of 2 quarters · filed 2024-11-04 | $101.00K 10-Q · filed 2024-11-04 | $3.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $103.00K 10-Q · filed 2024-08-08 | $5.00K derived: sum of 3 quarters · filed 2025-03-17 | $18.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $106.00K 10-Q · filed 2024-05-08 | $8.00K derived: sum of 2 quarters · filed 2025-03-17 | $21.00K derived: sum of 3 quarters · filed 2025-03-17 | $53.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$85.00K derived: sum of 2 quarters · filed 2025-03-17 | -$53.00K derived: sum of 3 quarters · filed 2025-03-17 | $26.00K 10-K · filed 2025-03-17 | $158.00K 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $45.00K derived: sum of 2 quarters · filed 2023-11-03 | $124.00K 10-Q · filed 2023-11-03 | |||||
| 2022-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $111.00K 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | $79.00K 10-Q · filed 2023-05-09 | |||||||
| 2021-12-31 | $73.00K 10-K · filed 2024-03-15 | |||||||
| 2020-12-31 | $78.00K 10-K · filed 2023-03-16 | |||||||
| 2019-12-31 | $33.00K 10-K · filed 2022-03-11 | |||||||
| 2018-12-31 | $0.00 10-K/A · filed 2021-04-26 | |||||||
| 2017-12-31 | $6.00K 10-K · filed 2020-03-06 | |||||||
| 2016-12-31 | $16.00K 10-K · filed 2019-02-27 | |||||||
| 2015-12-31 | $3.00K 10-K · filed 2018-02-27 | |||||||
| 2014-12-31 | $377.00K 10-K · filed 2017-02-24 | $446.40K 10-K · filed 2015-03-13 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 | |||||||
| 2012-12-31 | $135.35K 10-K · filed 2015-03-13 | |||||||
| 2011-12-31 | $2.05K 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |